---
figid: PMC5825873__develop-145-152595-g2
figtitle: Pathways that regulate mTORC1 and mTORC2 signaling
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5825873
filename: develop-145-152595-g2.jpg
figlink: /pmc/articles/PMC5825873/figure/DEV152595F2/
number: F2
caption: Pathways that regulate mTORC1 and mTORC2 signaling. A schematic of a cell
  showing insulin and EGFR receptors at the plasma membrane, and components of the
  mTOR signaling pathways located near the lysosome. mTORC1 is controlled by growth
  factors via the PI3K-AKT and Ras-MAPK pathways. PI3K catalyzes the phosphorylation
  of PIP2 to PIP3, which in turn recruits PDK1 and AKT, facilitating the phosphorylation
  of AKT at T308 by PDK1. mTORC2 also phosphorylates AKT at S473. Activated AKT then
  promotes mTORC1 activity by inhibiting the GAP activity of the TSC, thus activating
  Rheb, a potent mTORC1 activator. The Ras-MAPK pathway regulates mTORC1 through the
  Ras-Raf-MEK-ERK signaling cascade. ERK or its downstream substrate RSK inhibits
  TSC by direct phosphorylation. In addition, mTORC1 is controlled by Wnt signaling
  (through GSK3), by TNFα (through IKKβ), by hypoxia (through REDD1) and by DNA damage
  (through p53). Energy stress also regulates mTORC1, acting via LKB1 and AMPK. Positive
  regulators of mTORC1 or mTORC2 are shown in green and negative regulators in red.
  AMPK, AMP-activated protein kinase; AKT, RAC-α serine/threonine-protein kinase;
  EGFR, epidermal growth factor receptor; ERK, extracellular signal-regulated kinase;
  GAP, GTPase activating protein; Grb2, growth factor receptor-bound protein 2; GSK3,
  glycogen synthase kinase 3; IKKβ, IκB kinase β; IRS, insulin receptor substrate;
  LKB1, liver kinase B1; MAPK, mitogen-activated protein kinase; MEK, MAPK/ERK kinase;
  mTOR, mammalian target of rapamycin or mechanistic target of rapamycin; mTORC1,
  mTOR complex 1; mTORC2, mTOR complex 2; p53, protein 53; PDK1, 3′-phosphoinositide-dependent
  kinase 1; PI3K, phosphoinositide 3 kinase; PIP2, phosphatidylinositol (4,5) bisphosphate;
  PIP3, phosphatidylinositol (3,4,5) trisphosphate; PTEN, phosphatase and tensin homolog;
  Raf, rapidly accelerated fibrosarcoma; Ras, rat sarcoma; REDD1, DNA damage response
  1; Rheb, Ras homolog enriched in brain; RSK, ribosomal S6 kinase; SOS, son of sevenless
  homolog; TNFα, tumor necrosis factor α; TSC1/2, tuberous sclerosis complex 1/2;
  Wnt, wingless-type.
papertitle: mTOR signaling in stem and progenitor cells.
reftext: Delong Meng, et al. Development. 2018 Jan 1;145(1):dev152595.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9265298
figid_alias: PMC5825873__F2
figtype: Figure
redirect_from: /figures/PMC5825873__F2
ndex: 0d40986a-df0c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5825873__develop-145-152595-g2.html
  '@type': Dataset
  description: Pathways that regulate mTORC1 and mTORC2 signaling. A schematic of
    a cell showing insulin and EGFR receptors at the plasma membrane, and components
    of the mTOR signaling pathways located near the lysosome. mTORC1 is controlled
    by growth factors via the PI3K-AKT and Ras-MAPK pathways. PI3K catalyzes the phosphorylation
    of PIP2 to PIP3, which in turn recruits PDK1 and AKT, facilitating the phosphorylation
    of AKT at T308 by PDK1. mTORC2 also phosphorylates AKT at S473. Activated AKT
    then promotes mTORC1 activity by inhibiting the GAP activity of the TSC, thus
    activating Rheb, a potent mTORC1 activator. The Ras-MAPK pathway regulates mTORC1
    through the Ras-Raf-MEK-ERK signaling cascade. ERK or its downstream substrate
    RSK inhibits TSC by direct phosphorylation. In addition, mTORC1 is controlled
    by Wnt signaling (through GSK3), by TNFα (through IKKβ), by hypoxia (through REDD1)
    and by DNA damage (through p53). Energy stress also regulates mTORC1, acting via
    LKB1 and AMPK. Positive regulators of mTORC1 or mTORC2 are shown in green and
    negative regulators in red. AMPK, AMP-activated protein kinase; AKT, RAC-α serine/threonine-protein
    kinase; EGFR, epidermal growth factor receptor; ERK, extracellular signal-regulated
    kinase; GAP, GTPase activating protein; Grb2, growth factor receptor-bound protein
    2; GSK3, glycogen synthase kinase 3; IKKβ, IκB kinase β; IRS, insulin receptor
    substrate; LKB1, liver kinase B1; MAPK, mitogen-activated protein kinase; MEK,
    MAPK/ERK kinase; mTOR, mammalian target of rapamycin or mechanistic target of
    rapamycin; mTORC1, mTOR complex 1; mTORC2, mTOR complex 2; p53, protein 53; PDK1,
    3′-phosphoinositide-dependent kinase 1; PI3K, phosphoinositide 3 kinase; PIP2,
    phosphatidylinositol (4,5) bisphosphate; PIP3, phosphatidylinositol (3,4,5) trisphosphate;
    PTEN, phosphatase and tensin homolog; Raf, rapidly accelerated fibrosarcoma; Ras,
    rat sarcoma; REDD1, DNA damage response 1; Rheb, Ras homolog enriched in brain;
    RSK, ribosomal S6 kinase; SOS, son of sevenless homolog; TNFα, tumor necrosis
    factor α; TSC1/2, tuberous sclerosis complex 1/2; Wnt, wingless-type.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - Pten
  - drk
  - Sos
  - IRSp53
  - IleRS
  - chico
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pdk1
  - Raf
  - Erk7
  - rl
  - Akt
  - S6kII
  - p53
  - betaTub60D
  - hth
  - Lkb1
  - SNF4Agamma
  - AMPKalpha
  - Tsc
  - Tsc1
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - sgg
  - egr
  - IKKbeta
  - Rheb
  - Crtc
  - Dsor1
  - Mtk
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - TP53
  - TP63
  - TP73
  - STK11
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - GSK3A
  - GSK3B
  - TNF
  - IKBKB
  - RHEB
  - RHEBP1
  - RPTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - DDIT4
  - Amino acids
  - Hypoxia
---
